PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 31, 2026Journal of the American College of Cardiology2 citations

Effect of Tocilizumab on Pro–B-Type Natriuretic Peptide and Infarct Size in Patients With Acute Myocardial Infarction at Risk of Cardiogenic Shock (DOBERMANN-T)

View Full Paper
JKJoakim Bo KunkelSHSarah Louise Duus HolleCHChristian Hassager

Key Points

Key points are not available for this paper at this time.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Kunkel et al. (2026) studied this question.

synapsesocial.com/papers/6a025c99edf6f481385947cbhttps://doi.org/10.1016/j.jacc.2026.01.019
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Predicting the development of in-hospital cardiogenic shock in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: the ORBI risk score2018 · 118 citations
  2. 2Criteria for Defining Stages of Cardiogenic Shock Severity2022 · 310 citations
  3. 3Prehospital Pulse-Dose Glucocorticoid in ST-Segment Elevation Myocardial Infarction2024 · 20 citations
  4. 4Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial2016 · 396 citations
  5. 5Interleukin-6 receptor antibodies (tocilizumab) in acute myocardial infarction with intermediate to high risk of cardiogenic shock development (DOBERMANN-T): study protocol for a double-blinded, placebo-controlled, single-center, randomized clinical trial2024 · 13 citations